Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Japanese encephalitis virus (JEV)
- Target
- JEV
- Molecular classification
- Virus, Flavivirus
01
Overview
Japanese encephalitis virus (JEV) is a mosquito-borne flavivirus and the leading cause of viral encephalitis in Asia. It is closely related to other flaviviruses such as dengue, yellow fever, Zika, and West Nile viruses. JEV primarily affects children in endemic regions but can infect individuals of any age.
- Other names
- JEV
02
Mechanism of action
Vaccines stimulate the production of neutralizing antibodies against JEV
03
Biological functions
Viral replicationInfectionImmune evasion
04
Disease associations
Japanese encephalitisEncephalitis
05
Safety considerations
Vaccine-related adverse events (rare)
06
Interacting drugs
Vaccines targeting JEV antigens
Beyond the preview
Go deeper on Japanese encephalitis virus (JEV).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Japanese encephalitis virus (JEV).